A four-gene model of MM consisting of FAM53B, KIF21B, WHSC1, and TMPO could predict the overall survival of MM patients independently, and the expression of FAM53B was downregulated in high-risk patients compared to low-risk patients. This evidence concerns the gene KIF21B and Miyoshi myopathy.